124 related articles for article (PubMed ID: 3291158)
1. Colloidal bismuth subcitrate.
Simjee AE
S Afr Med J; 1988 Jul; 74 Suppl():61-3. PubMed ID: 3291158
[No Abstract] [Full Text] [Related]
2. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
3. Recurrent ulcer treated with colloidal bismuth.
Koo J; Lam SK
Med J Aust; 1983 Feb; 1(3):103-4. PubMed ID: 6571529
[No Abstract] [Full Text] [Related]
4. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
Chearanai O; Kachintorn U; Plengvanit U
J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
[No Abstract] [Full Text] [Related]
8. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
Maev IV; Samsonov AA; Golubev NN
Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841
[TBL] [Abstract][Full Text] [Related]
9. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
[No Abstract] [Full Text] [Related]
10. [A consensus on some problems of Helicobacter pylori (draft)].
Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):438-9. PubMed ID: 10436941
[No Abstract] [Full Text] [Related]
11. [De-nol in NSAID-induced gastroduodenal lesions].
Cataldo MG; D'Aiuto A; Bongiorno A
Minerva Dietol Gastroenterol; 1990; 36(1):27-30. PubMed ID: 2186304
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
[No Abstract] [Full Text] [Related]
13. Site-and cytoprotective drugs in the short-term treatment of peptic ulcer. What is their current role?
Bianchi Porro G; Parente F
Ital J Gastroenterol; 1990; 22 Suppl 1():5-10. PubMed ID: 1983422
[TBL] [Abstract][Full Text] [Related]
14. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
Pan SA; Liao CH; Lien GS; Chen SH
Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
[TBL] [Abstract][Full Text] [Related]
15. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
Hu FL; Jia BQ; Gao HZ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the efficacy of ranitidine, cimetidine (Asiloc), De-Nol and spirulina in the treatment of gastric and duodenal ulcer].
Fica V; Andronescu D; Olteanu D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):21-35. PubMed ID: 2884709
[No Abstract] [Full Text] [Related]
18. Present and future treatment of peptic ulcer and potential role of DE-NOL.
Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
[No Abstract] [Full Text] [Related]
19. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Karateev AE; Nasonov EL; Radenska-Lopovok SG
Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report.
Papp J; Juhasz L; Lakatos L; Lonovits J; Szekely I; Tarnok F; Tulassay Z; Varkonyi T
Br J Clin Pract; 1996; 50(5):249-53. PubMed ID: 8794601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
